PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.01%
Net income growth under 50% of CRWV's 24.23%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
1.21%
Less D&A growth vs. CRWV's 49.09%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
69.92%
Some yoy growth while CRWV is negative at -8.94%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
3.77%
SBC growth well above CRWV's 1.15%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-43.01%
Negative yoy working capital usage while CRWV is 8747.97%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
198.13%
AR growth well above CRWV's 150.25%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-235.03%
Negative yoy inventory while CRWV is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-7.40%
Negative yoy AP while CRWV is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-167.56%
Negative yoy usage while CRWV is 2109.54%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-68.18%
Both negative yoy, with CRWV at -24.75%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
6.30%
Operating cash flow growth below 50% of CRWV's 4574.44%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-10.89%
Both yoy lines negative, with CRWV at -47.61%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-247.80%
Negative yoy acquisition while CRWV stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
29.36%
Purchases growth of 29.36% while CRWV is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
69.81%
Liquidation growth of 69.81% while CRWV is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-265.06%
We reduce yoy other investing while CRWV is 60.60%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
105.51%
We have mild expansions while CRWV is negative at -41.20%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-50.00%
Both yoy lines negative, with CRWV at -25.92%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
33.79%
Issuance growth of 33.79% while CRWV is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
15.31%
Buyback growth below 50% of CRWV's 100.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.